| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 3.53e-07 | 4 | 90 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.75e-06 | 6 | 90 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.43e-05 | 33 | 90 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | collagen binding | 3.25e-05 | 81 | 90 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 6.88e-05 | 18 | 90 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.33e-04 | 334 | 90 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 1.47e-04 | 23 | 90 | 3 | GO:0030021 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.08e-04 | 188 | 90 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.25e-04 | 459 | 90 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.95e-04 | 129 | 90 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.63e-04 | 31 | 90 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.30e-04 | 140 | 90 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | channel activity | 5.99e-04 | 525 | 90 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.07e-04 | 151 | 90 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.07e-04 | 526 | 90 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 7.09e-04 | 9 | 90 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 7.09e-04 | 9 | 90 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 8.83e-04 | 10 | 90 | 2 | GO:0033550 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 9.15e-04 | 343 | 90 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 1.08e-03 | 11 | 90 | 2 | GO:0008330 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.17e-03 | 46 | 90 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.40e-03 | 182 | 90 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.47e-03 | 184 | 90 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 1.52e-03 | 13 | 90 | 2 | GO:0017017 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.76e-03 | 14 | 90 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.81e-03 | 193 | 90 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.98e-03 | 197 | 90 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 2.28e-03 | 58 | 90 | 3 | GO:0051018 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 2.61e-03 | 17 | 90 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 2.93e-03 | 18 | 90 | 2 | GO:0033549 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B SLC26A8 CLCN2 ATP1B2 HCN2 CHRNB2 RYR1 RYR2 RYR3 | 3.00e-03 | 793 | 90 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 3.40e-03 | 807 | 90 | 10 | GO:0016788 | |
| GeneOntologyBiologicalProcess | eye development | RPGRIP1 COL8A1 XRN2 CELF4 RARA RARB CLCN2 PITX2 LAMA1 MAB21L2 MAB21L1 | 8.56e-06 | 480 | 91 | 11 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | RPGRIP1 COL8A1 XRN2 CELF4 RARA RARB CLCN2 PITX2 LAMA1 MAB21L2 MAB21L1 | 9.07e-06 | 483 | 91 | 11 | GO:0150063 |
| GeneOntologyBiologicalProcess | sensory system development | RPGRIP1 COL8A1 XRN2 CELF4 RARA RARB CLCN2 PITX2 LAMA1 MAB21L2 MAB21L1 | 1.06e-05 | 491 | 91 | 11 | GO:0048880 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.34e-05 | 11 | 91 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | camera-type eye development | RPGRIP1 COL8A1 XRN2 CELF4 RARA CLCN2 PITX2 LAMA1 MAB21L2 MAB21L1 | 1.84e-05 | 426 | 91 | 10 | GO:0043010 |
| GeneOntologyBiologicalProcess | response to ATP | 2.87e-05 | 40 | 91 | 4 | GO:0033198 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 2.92e-05 | 14 | 91 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell differentiation | 7.65e-05 | 19 | 91 | 3 | GO:0055012 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 9.40e-05 | 166 | 91 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.04e-04 | 21 | 91 | 3 | GO:0031000 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.75e-05 | 73 | 92 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 4.98e-05 | 46 | 92 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 2.63e-04 | 378 | 92 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.94e-04 | 523 | 92 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | cation channel complex | 6.03e-04 | 235 | 92 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | junctional membrane complex | 6.76e-04 | 9 | 92 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | transporter complex | 7.08e-04 | 550 | 92 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.43e-04 | 10 | 92 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.02e-03 | 45 | 92 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.09e-03 | 46 | 92 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 1.23e-03 | 12 | 92 | 2 | GO:0097450 | |
| HumanPheno | Recurrent patellar dislocation | 1.66e-05 | 7 | 41 | 3 | HP:0005001 | |
| MousePheno | abnormal mitochondrial morphology | 9.31e-06 | 209 | 70 | 8 | MP:0006035 | |
| MousePheno | abnormal summary potential | 7.39e-05 | 3 | 70 | 2 | MP:0003470 | |
| MousePheno | absent lens vesicle | 7.39e-05 | 3 | 70 | 2 | MP:0009725 | |
| MousePheno | abnormal heart development | 9.43e-05 | 372 | 70 | 9 | MP:0000267 | |
| MousePheno | abnormal spinal reflex | 9.55e-05 | 148 | 70 | 6 | MP:0012079 | |
| MousePheno | abnormal response to tactile stimuli | 9.55e-05 | 148 | 70 | 6 | MP:0005316 | |
| Domain | Ryanodine_rcpt | 1.12e-07 | 3 | 91 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.12e-07 | 3 | 91 | 3 | IPR009460 | |
| Domain | RyR | 1.12e-07 | 3 | 91 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 1.12e-07 | 3 | 91 | 3 | PF06459 | |
| Domain | Ryan_recept | 1.12e-07 | 3 | 91 | 3 | IPR013333 | |
| Domain | RIH_assoc-dom | 2.21e-06 | 6 | 91 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 2.21e-06 | 6 | 91 | 3 | PF08709 | |
| Domain | RIH_assoc | 2.21e-06 | 6 | 91 | 3 | PF08454 | |
| Domain | RIH_dom | 2.21e-06 | 6 | 91 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.21e-06 | 6 | 91 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.21e-06 | 6 | 91 | 3 | IPR015925 | |
| Domain | - | 2.21e-06 | 6 | 91 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.21e-06 | 6 | 91 | 3 | PF01365 | |
| Domain | MIR | 1.31e-05 | 10 | 91 | 3 | PF02815 | |
| Domain | MIR_motif | 1.31e-05 | 10 | 91 | 3 | IPR016093 | |
| Domain | MIR | 1.31e-05 | 10 | 91 | 3 | PS50919 | |
| Domain | MIR | 1.31e-05 | 10 | 91 | 3 | SM00472 | |
| Domain | Ion_trans_dom | 1.98e-05 | 114 | 91 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.98e-05 | 114 | 91 | 6 | PF00520 | |
| Domain | CHN1/CHN2 | 2.35e-05 | 2 | 91 | 2 | IPR017356 | |
| Domain | Retinoic_acid_rcpt | 1.40e-04 | 4 | 91 | 2 | IPR003078 | |
| Domain | - | 1.72e-04 | 321 | 91 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 1.99e-04 | 328 | 91 | 8 | IPR032675 | |
| Domain | Mab-21-like_1/2 | 2.33e-04 | 5 | 91 | 2 | IPR020950 | |
| Domain | ARM-type_fold | 2.49e-04 | 339 | 91 | 8 | IPR016024 | |
| Domain | Leu-rich_rpt | 3.59e-04 | 271 | 91 | 7 | IPR001611 | |
| Domain | Ca_chan_IQ | 4.85e-04 | 7 | 91 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 4.85e-04 | 7 | 91 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 4.85e-04 | 7 | 91 | 2 | IPR014873 | |
| Domain | GPHH | 4.85e-04 | 7 | 91 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.85e-04 | 7 | 91 | 2 | IPR031649 | |
| Domain | LRR_1 | 7.06e-04 | 219 | 91 | 6 | PF00560 | |
| Domain | MKP | 1.03e-03 | 10 | 91 | 2 | IPR008343 | |
| Domain | VDCCAlpha1 | 1.03e-03 | 10 | 91 | 2 | IPR002077 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | IPR000372 | |
| Domain | LRRNT | 1.34e-03 | 98 | 91 | 4 | SM00013 | |
| Domain | LRR_8 | 1.50e-03 | 171 | 91 | 5 | PF13855 | |
| Domain | Mab-21 | 1.50e-03 | 12 | 91 | 2 | PF03281 | |
| Domain | Mab-21 | 1.50e-03 | 12 | 91 | 2 | SM01265 | |
| Domain | Mab-21_dom | 1.50e-03 | 12 | 91 | 2 | IPR024810 | |
| Domain | LRR_TYP | 1.74e-03 | 177 | 91 | 5 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.74e-03 | 177 | 91 | 5 | IPR003591 | |
| Domain | - | 1.77e-03 | 13 | 91 | 2 | 3.40.50.20 | |
| Domain | ATP_GRASP | 2.06e-03 | 14 | 91 | 2 | PS50975 | |
| Domain | ATP-grasp | 2.06e-03 | 14 | 91 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 2.06e-03 | 14 | 91 | 2 | IPR016185 | |
| Domain | LRRNT | 2.20e-03 | 53 | 91 | 3 | PF01462 | |
| Domain | FH2 | 2.37e-03 | 15 | 91 | 2 | PS51444 | |
| Domain | FH2_Formin | 2.37e-03 | 15 | 91 | 2 | IPR015425 | |
| Domain | FH2 | 2.37e-03 | 15 | 91 | 2 | PF02181 | |
| Domain | - | 2.37e-03 | 15 | 91 | 2 | 3.30.1490.20 | |
| Domain | FH2 | 2.37e-03 | 15 | 91 | 2 | SM00498 | |
| Domain | C1_1 | 2.71e-03 | 57 | 91 | 3 | PF00130 | |
| Domain | LRR | 3.02e-03 | 201 | 91 | 5 | PS51450 | |
| Domain | ATP_grasp_subdomain_1 | 3.41e-03 | 18 | 91 | 2 | IPR013815 | |
| Domain | - | 3.41e-03 | 18 | 91 | 2 | 3.30.470.20 | |
| Domain | ZF_DAG_PE_1 | 3.76e-03 | 64 | 91 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.76e-03 | 64 | 91 | 3 | PS50081 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 3.80e-03 | 19 | 91 | 2 | IPR006553 | |
| Domain | LRR_CC | 3.80e-03 | 19 | 91 | 2 | SM00367 | |
| Domain | C1 | 3.93e-03 | 65 | 91 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 4.10e-03 | 66 | 91 | 3 | IPR002219 | |
| Domain | ConA-like_dom | 4.35e-03 | 219 | 91 | 5 | IPR013320 | |
| Domain | DAG/PE-bd | 4.64e-03 | 21 | 91 | 2 | IPR020454 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.09e-09 | 11 | 69 | 5 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 3.10e-05 | 13 | 69 | 3 | M39589 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 8.10e-05 | 147 | 69 | 6 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.40e-05 | 151 | 69 | 6 | M39329 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.03e-04 | 19 | 69 | 3 | M47760 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.38e-04 | 54 | 69 | 4 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.38e-04 | 54 | 69 | 4 | MM15202 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.95e-04 | 59 | 69 | 4 | M46460 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 2.31e-04 | 178 | 69 | 6 | M2890 | |
| Pathway | WP_VITAMIN_A1_AND_A5X_PATHWAYS | 3.50e-04 | 6 | 69 | 2 | M48097 | |
| Pathway | REACTOME_SIGNALING_BY_MAPK_MUTANTS | 4.88e-04 | 7 | 69 | 2 | M38997 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18403125 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 7876312 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 1.79e-08 | 3 | 92 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 1.79e-08 | 3 | 92 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 1.79e-08 | 3 | 92 | 3 | 10473538 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18313230 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 1.79e-08 | 3 | 92 | 3 | 9204703 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 1.79e-08 | 3 | 92 | 3 | 12213830 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 9242641 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 25239916 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 18643873 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 11159936 | ||
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 1.79e-08 | 3 | 92 | 3 | 4600883 | |
| Pubmed | 1.79e-08 | 3 | 92 | 3 | 7635066 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 5.44e-08 | 38 | 92 | 5 | 30786075 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 7.15e-08 | 4 | 92 | 3 | 23413940 | |
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 9607712 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 23482488 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 18206662 | ||
| Pubmed | 7.15e-08 | 4 | 92 | 3 | 9384575 | ||
| Pubmed | 1.78e-07 | 5 | 92 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 1.78e-07 | 5 | 92 | 3 | 19011160 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.56e-07 | 6 | 92 | 3 | 26025922 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 3.56e-07 | 6 | 92 | 3 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.56e-07 | 6 | 92 | 3 | 25966694 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 19009018 | ||
| Pubmed | An evolutionarily conserved nested gene pair - Mab21 and Lrba/Nbea in metazoan. | 3.56e-07 | 6 | 92 | 3 | 19482073 | |
| Pubmed | 3.56e-07 | 6 | 92 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.56e-07 | 6 | 92 | 3 | 16844763 | |
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 11860456 | ||
| Pubmed | 6.22e-07 | 7 | 92 | 3 | 20962236 | ||
| Pubmed | 9.94e-07 | 8 | 92 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 9.94e-07 | 8 | 92 | 3 | 19033399 | |
| Pubmed | 2.12e-06 | 10 | 92 | 3 | 18539269 | ||
| Pubmed | 3.87e-06 | 12 | 92 | 3 | 19095005 | ||
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 6.92e-06 | 2 | 92 | 2 | 29921692 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 6.92e-06 | 2 | 92 | 2 | 23426690 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9489997 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1330302 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 17259277 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 6.92e-06 | 2 | 92 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 6.92e-06 | 2 | 92 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 6.92e-06 | 2 | 92 | 2 | 26009179 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 32899693 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 14592949 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 23376566 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 8898078 | ||
| Pubmed | Expression of mouse Tbx22 supports its role in palatogenesis and glossogenesis. | 6.92e-06 | 2 | 92 | 2 | 12666195 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 24833708 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 14550562 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9799464 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 38155373 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7644503 | ||
| Pubmed | Protein instability associated with AARS1 and MARS1 mutations causes trichothiodystrophy. | 6.92e-06 | 2 | 92 | 2 | 33909043 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11857508 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 6.92e-06 | 2 | 92 | 2 | 15033925 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 6.92e-06 | 2 | 92 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 6.92e-06 | 2 | 92 | 2 | 11500519 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.92e-06 | 2 | 92 | 2 | 21531043 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 16678258 | ||
| Pubmed | The Male Abnormal Gene Family 21 (Mab21) Members Regulate Eye Development. | 6.92e-06 | 2 | 92 | 2 | 27558071 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12565913 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9192302 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9168777 | ||
| Pubmed | Prognostic significance of serum chemerin levels in patients with non-small cell lung cancer. | 6.92e-06 | 2 | 92 | 2 | 28160556 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 7556644 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 1334013 | ||
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 6.92e-06 | 2 | 92 | 2 | 15894801 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30542613 | ||
| Pubmed | Genomic cloning and chromosomal localization of the mouse Mab21l2 locus. | 6.92e-06 | 2 | 92 | 2 | 10516425 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15159591 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 30601638 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15280431 | ||
| Pubmed | Expression of the ryanodine receptor isoforms in immune cells. | 6.92e-06 | 2 | 92 | 2 | 11673493 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 11673462 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 9817784 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 27306217 | ||
| Pubmed | Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain. | 6.92e-06 | 2 | 92 | 2 | 25370123 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 14985349 | ||
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 15050706 | ||
| Pubmed | Thermodynamics of calmodulin binding to cardiac and skeletal muscle ryanodine receptor ion channels. | 6.92e-06 | 2 | 92 | 2 | 18618700 | |
| Pubmed | 6.92e-06 | 2 | 92 | 2 | 12009305 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 30635578 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 7607068 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 7607067 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 11172439 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 11171121 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 8383767 | ||
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 2.07e-05 | 3 | 92 | 2 | 1655807 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 29466725 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 2.07e-05 | 3 | 92 | 2 | 29730765 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 9659935 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 11245412 | ||
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 23969901 | ||
| Cytoband | 13q13 | 3.96e-05 | 5 | 92 | 2 | 13q13 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.47e-08 | 3 | 60 | 3 | 287 | |
| GeneFamily | MAP kinase phosphatases | 5.84e-04 | 11 | 60 | 2 | 895 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 7.00e-04 | 12 | 60 | 2 | 573 | |
| GeneFamily | F-box and leucine rich repeat proteins | 2.18e-03 | 21 | 60 | 2 | 558 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.34e-03 | 26 | 60 | 2 | 253 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CACNA1B COL8A1 CELF4 RIMKLB RARB RPRM PITX2 DISP2 MAB21L2 GCN1 MAB21L1 MED13 RYR2 RYR3 | 7.40e-06 | 818 | 89 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | DOCK4 CACNA1B CELF5 COL8A1 RIMKLB RARB RPRM PITX2 NBEA CHN2 MAB21L1 RYR2 RYR3 | 3.94e-05 | 827 | 89 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | TBX22 CACNA1A ZC3H7A COL8A1 CELF4 AEBP1 NEXMIF PKP3 PITX2 PODN C1orf216 MAB21L2 ATP1B2 DCN | 4.74e-05 | 967 | 89 | 14 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 6.21e-05 | 416 | 89 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | DOCK4 RIMKLB RARB AEBP1 NEXMIF LAMA1 BACE2 ATP1B2 DCN B4GALT5 RYR2 PLCE1 | 1.20e-04 | 797 | 89 | 12 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 1.28e-04 | 357 | 89 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | CACNA1B CELF5 COL8A1 CELF4 RIMKLB RARB RPRM DISP2 MAB21L1 MED13 RYR2 RYR3 | 1.53e-04 | 818 | 89 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.62e-04 | 193 | 89 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | TBX22 CACNA1A ZC3H7A COL8A1 NEXMIF PKP3 DUSP6 PITX2 PKLR PODN MAB21L2 ATP1B2 MAB21L1 | 1.89e-04 | 967 | 89 | 13 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | TBX22 CACNA1A CACNA1B ZC3H7A COL8A1 RARB NEXMIF PKP3 DUSP6 PKLR PODN MAB21L2 ATP1B2 | 1.91e-04 | 968 | 89 | 13 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.12e-07 | 184 | 92 | 7 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.20e-07 | 186 | 92 | 7 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-3|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.44e-07 | 191 | 92 | 7 | 80d30d8eedb4c70b58440646325bc04c5700803e | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Fibroblasts|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.65e-07 | 195 | 92 | 7 | 5870b2956d50d6550a3174a220a6cc70c5538d70 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.71e-07 | 196 | 92 | 7 | d37d821229dce716a05c2a5865415e10f79032de | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.71e-07 | 196 | 92 | 7 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.84e-07 | 198 | 92 | 7 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.96e-07 | 200 | 92 | 7 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | ASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.35e-06 | 168 | 92 | 6 | c399fcb4d1d0be48026c2ecabc34a5935e7adf73 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 1.50e-06 | 171 | 92 | 6 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-06 | 175 | 92 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.09e-06 | 181 | 92 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-06 | 182 | 92 | 6 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | COPD-Myeloid-Mast|World / Disease state, Lineage and Cell class | 2.16e-06 | 182 | 92 | 6 | 68a1e7b804f309bfd6c23d65fad20a9a962712ae | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-06 | 184 | 92 | 6 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-06 | 184 | 92 | 6 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-06 | 185 | 92 | 6 | 3fafb1d36c5f98a29d20a5ce5192c83d6f603514 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 187 | 92 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-06 | 192 | 92 | 6 | 1ee4783051ec94ea94600f040edcb385fc4289f1 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.03e-06 | 193 | 92 | 6 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 3.12e-06 | 194 | 92 | 6 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-06 | 194 | 92 | 6 | 5da8873cddff582e5693b32fd3aaebc102f65fc0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-06 | 195 | 92 | 6 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-06 | 196 | 92 | 6 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-06 | 196 | 92 | 6 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.31e-06 | 196 | 92 | 6 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.40e-06 | 197 | 92 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-06 | 197 | 92 | 6 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 198 | 92 | 6 | 07701c73137947ed4a27e225975329235bbb8734 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 3.51e-06 | 198 | 92 | 6 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 198 | 92 | 6 | fa84bf8533d1b91d2c2bcf06b710670605072b89 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-06 | 198 | 92 | 6 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Sigmoid-(7)_Mast_cell-(70)_Mast|Sigmoid / shred on region, Cell_type, and subtype | 3.71e-06 | 200 | 92 | 6 | 7224ee639d56509de854203653a85ab09e6f05fe | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.71e-06 | 200 | 92 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.71e-06 | 200 | 92 | 6 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Myofibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.71e-06 | 200 | 92 | 6 | ca777a7d001848f6d01c613ff2bda7e4f3e20521 | |
| ToppCell | Sigmoid-Mast_cell|Sigmoid / Region, Cell class and subclass | 3.71e-06 | 200 | 92 | 6 | 025125d8b9c6540d9cdeea7f0fe9c58aec2a16b0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | Sigmoid-(7)_Mast_cell|Sigmoid / shred on region, Cell_type, and subtype | 3.71e-06 | 200 | 92 | 6 | bd8e0f027055bb34e99aa0e271ec3a0912f666bb | |
| ToppCell | Sigmoid-Mast_cell-Mast|Sigmoid / Region, Cell class and subclass | 3.71e-06 | 200 | 92 | 6 | e7e49e192a86566ed96f1e54657dd2ebc9036d47 | |
| ToppCell | (5)_Fibroblast-B_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.71e-06 | 200 | 92 | 6 | 9bbaa666d0f3b4782c1b4b95e0fa5fc1467842d8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.71e-06 | 200 | 92 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.44e-06 | 126 | 92 | 5 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.50e-05 | 150 | 92 | 5 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.76e-05 | 155 | 92 | 5 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.81e-05 | 156 | 92 | 5 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 156 | 92 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 1.81e-05 | 156 | 92 | 5 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-05 | 156 | 92 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.30e-05 | 164 | 92 | 5 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 2.30e-05 | 164 | 92 | 5 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-05 | 165 | 92 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 167 | 92 | 5 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 167 | 92 | 5 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-05 | 167 | 92 | 5 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 167 | 92 | 5 | e228b8373ffd4436e6b944e26d0fadf3ac289b21 | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.51e-05 | 167 | 92 | 5 | de0cb257def6049830af068f8f74829a708b810f | |
| ToppCell | ILEUM-non-inflamed-(4)_Mast_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.51e-05 | 167 | 92 | 5 | 85b39e05eb6e18e06b47e374d808e479ca65173c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 167 | 92 | 5 | 7cb1b11e8e24a10115e46ffbb74889e672a7a026 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-05 | 167 | 92 | 5 | bb53a478b5d821d6d82c15bc4ed075b67682457c | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.74e-05 | 170 | 92 | 5 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 172 | 92 | 5 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 172 | 92 | 5 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 172 | 92 | 5 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-05 | 172 | 92 | 5 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 173 | 92 | 5 | e944ea3a0a368f856efacbda4600605cf751dd9c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.98e-05 | 173 | 92 | 5 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-05 | 173 | 92 | 5 | 85fa5918e9c1f6bb4757e3350cfc71ee75c55640 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 174 | 92 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-05 | 174 | 92 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.06e-05 | 174 | 92 | 5 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-05 | 174 | 92 | 5 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 177 | 92 | 5 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | Adult-Epithelial-club_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.32e-05 | 177 | 92 | 5 | d652b7d84fe6aa38319d8d5adc72c70441bd0088 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-05 | 177 | 92 | 5 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 3.41e-05 | 178 | 92 | 5 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 178 | 92 | 5 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.41e-05 | 178 | 92 | 5 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-05 | 178 | 92 | 5 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 178 | 92 | 5 | bcbdd45a2307f8aea14122fa0144b96b1f6eec48 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.41e-05 | 178 | 92 | 5 | c413861148129be1ee94f2ceb5999840217eebe5 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-05 | 179 | 92 | 5 | 9dd8d19050223cdebec2579014892b759e5e9de8 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.50e-05 | 179 | 92 | 5 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.50e-05 | 179 | 92 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.50e-05 | 179 | 92 | 5 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 180 | 92 | 5 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.60e-05 | 180 | 92 | 5 | 2ccc77d769d3ffd77ab3af45e4f192785b6db79c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 180 | 92 | 5 | 3d54cc767e25d91ed2203d8a03e5bf5e15f21699 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 3.69e-05 | 181 | 92 | 5 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 181 | 92 | 5 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | 5'-Adult-LymphNode-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-05 | 182 | 92 | 5 | 49e4b362f88d235ed12aabcabb54787c16e32cb7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 182 | 92 | 5 | cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 3.89e-05 | 183 | 92 | 5 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-05 | 184 | 92 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | IPF-Myeloid-Mast|World / Disease state, Lineage and Cell class | 3.99e-05 | 184 | 92 | 5 | 7aefa182acad5a53c730945fec85329d7168606a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 184 | 92 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| Drug | cis-diammineplatinum(II | 6.38e-08 | 3 | 92 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 6.38e-08 | 3 | 92 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 6.38e-08 | 3 | 92 | 3 | CID000127713 | |
| Drug | aminodantrolene | 6.38e-08 | 3 | 92 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 6.38e-08 | 3 | 92 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 6.38e-08 | 3 | 92 | 3 | CID005748312 | |
| Drug | IAA-94 | 1.71e-07 | 61 | 92 | 6 | CID000003667 | |
| Drug | CNS 1145 | 2.09e-07 | 33 | 92 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.09e-07 | 33 | 92 | 5 | CID000162753 | |
| Drug | PCB74 | 2.55e-07 | 4 | 92 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 2.55e-07 | 4 | 92 | 3 | CID006444275 | |
| Drug | SC 38249 | 2.55e-07 | 4 | 92 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 2.55e-07 | 4 | 92 | 3 | CID000035682 | |
| Drug | phosphine oxide | 2.62e-07 | 107 | 92 | 7 | CID000166931 | |
| Drug | AC1L380G | 9.24e-07 | 19 | 92 | 4 | CID000084698 | |
| Drug | chloro-m-cresol | 1.27e-06 | 6 | 92 | 3 | CID000012008 | |
| Drug | MBED | 1.27e-06 | 6 | 92 | 3 | CID000129958 | |
| Drug | AC1O528X | 1.27e-06 | 6 | 92 | 3 | CID006475857 | |
| Drug | NSC114784 | 1.27e-06 | 6 | 92 | 3 | CID000419425 | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.42e-06 | 198 | 92 | 8 | 6603_DN | |
| Drug | nicardipine | 2.05e-06 | 145 | 92 | 7 | CID000004473 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.21e-06 | 7 | 92 | 3 | CID009547999 | |
| Drug | Azumoleno | 2.21e-06 | 7 | 92 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 2.21e-06 | 7 | 92 | 3 | CID003081001 | |
| Drug | nickel | CACNA1A CACNA1B RPGRIP1 NDRG1 NT5E POLG PKLR BACE2 RYR1 RYR2 RYR3 PLCE1 | 2.28e-06 | 552 | 92 | 12 | CID000000934 |
| Drug | Cinildipine | 3.13e-06 | 56 | 92 | 5 | CID000002752 | |
| Drug | manganese | CACNA1A CACNA1B RAG2 NDRG1 NT5E POLG LAMA1 PKLR ITGA10 PC CHRNB2 RYR1 RYR2 RYR3 | 3.40e-06 | 791 | 92 | 14 | CID000023930 |
| Drug | nilvadipine | 4.42e-06 | 60 | 92 | 5 | CID000004494 | |
| Drug | lercanidipine | 5.64e-06 | 63 | 92 | 5 | CID000065866 | |
| Drug | PCB 95 | 7.51e-06 | 10 | 92 | 3 | CID000038012 | |
| Drug | gallopamil | 7.65e-06 | 67 | 92 | 5 | CID000001234 | |
| Drug | AC1L2AC7 | 8.85e-06 | 69 | 92 | 5 | CID000068733 | |
| Drug | PCB 66 | 1.03e-05 | 11 | 92 | 3 | CID000036185 | |
| Drug | R 478 | 1.03e-05 | 11 | 92 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 1.03e-05 | 11 | 92 | 3 | CID003081323 | |
| Drug | phorbol acetate myristate | CACNA1A CACNA1B RAG2 RARA FCAR POLG ITGA10 DGKH APOB SSTR3 DCN CHN1 IL1RAP CHN2 RYR1 RYR2 RYR3 PLCE1 | 1.06e-05 | 1399 | 92 | 18 | CID000004792 |
| Drug | CAS 298-57-7 | 1.17e-05 | 73 | 92 | 5 | CID000002761 | |
| Drug | ethosuximide | 1.25e-05 | 74 | 92 | 5 | CID000003291 | |
| Drug | NSC759576 | 1.26e-05 | 191 | 92 | 7 | CID000003075 | |
| Drug | 3-7a | 1.33e-05 | 36 | 92 | 4 | CID011987860 | |
| Drug | Ryanodine | 1.37e-05 | 12 | 92 | 3 | ctd:D012433 | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 1.49e-05 | 196 | 92 | 7 | 3724_DN | |
| Drug | AC1L1IZE | 1.54e-05 | 131 | 92 | 6 | CID000004799 | |
| Drug | nisoldipine | 1.61e-05 | 78 | 92 | 5 | CID000004499 | |
| Drug | Ro 8-8717 | 1.62e-05 | 2 | 92 | 2 | CID006438148 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.62e-05 | 2 | 92 | 2 | ctd:C005147 | |
| Drug | 1-methoxyspirobrassinin | 1.62e-05 | 2 | 92 | 2 | CID011425998 | |
| Drug | Tamibarotene | 1.62e-05 | 2 | 92 | 2 | DB04942 | |
| Drug | Amidopyrine [58-15-1]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.64e-05 | 199 | 92 | 7 | 6818_UP | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.69e-05 | 200 | 92 | 7 | 5603_DN | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.72e-05 | 79 | 92 | 5 | CID005287890 | |
| Drug | E 14 | 1.84e-05 | 39 | 92 | 4 | CID000122591 | |
| Drug | dipyrone | 2.04e-05 | 40 | 92 | 4 | CID000003110 | |
| Drug | gamma-aminobutyric acid | 2.18e-05 | 474 | 92 | 10 | CID000000119 | |
| Drug | FPL 64176 | 2.80e-05 | 15 | 92 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 2.80e-05 | 15 | 92 | 3 | CID000125015 | |
| Drug | sesaminol | 2.80e-05 | 15 | 92 | 3 | CID000094672 | |
| Drug | cobalt-60 | 2.87e-05 | 390 | 92 | 9 | CID000061492 | |
| Drug | tetracaine | 2.90e-05 | 88 | 92 | 5 | CID000005411 | |
| Drug | DM-nitrophen | 3.44e-05 | 16 | 92 | 3 | CID000003083 | |
| Drug | procaine | 3.70e-05 | 153 | 92 | 6 | CID000004914 | |
| Drug | lindane | 3.84e-05 | 154 | 92 | 6 | CID000000727 | |
| Drug | kazinol B | 4.17e-05 | 17 | 92 | 3 | CID000480869 | |
| Drug | manidipine | 4.20e-05 | 95 | 92 | 5 | CID000004008 | |
| Drug | oxalate | 4.43e-05 | 158 | 92 | 6 | CID000000971 | |
| Drug | isotetrandrine | 4.64e-05 | 97 | 92 | 5 | CID000005422 | |
| Drug | vinylmagnesium bromide | 4.83e-05 | 3 | 92 | 2 | CID000074584 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 4.83e-05 | 3 | 92 | 2 | CID000080262 | |
| Drug | flubendiamide | 4.83e-05 | 3 | 92 | 2 | CID011193251 | |
| Drug | nitrendipine | 4.87e-05 | 98 | 92 | 5 | CID000004507 | |
| Drug | HX600 | 4.99e-05 | 18 | 92 | 3 | CID000128016 | |
| Drug | methylcoumarin | 4.99e-05 | 18 | 92 | 3 | CID000007092 | |
| Drug | isradipine | 5.37e-05 | 100 | 92 | 5 | CID000003784 | |
| Drug | AC1MW7VF | 5.90e-05 | 19 | 92 | 3 | CID000414699 | |
| Drug | gabapentin | 6.44e-05 | 169 | 92 | 6 | CID000003446 | |
| Drug | loperamide | 6.78e-05 | 105 | 92 | 5 | CID000003954 | |
| Drug | indo-1/AM | 8.06e-05 | 21 | 92 | 3 | CID000123918 | |
| Drug | papaverine | 8.06e-05 | 176 | 92 | 6 | CID000004680 | |
| Drug | thiopental | 9.21e-05 | 112 | 92 | 5 | CID003000715 | |
| Drug | adapalene | 9.30e-05 | 22 | 92 | 3 | CID000060164 | |
| Drug | A-30 | 9.64e-05 | 4 | 92 | 2 | CID003028528 | |
| Drug | SRI 5898-21 | 9.64e-05 | 4 | 92 | 2 | CID006439757 | |
| Drug | Tazarotene | 9.64e-05 | 4 | 92 | 2 | DB00799 | |
| Drug | AC 110 | 9.64e-05 | 4 | 92 | 2 | CID000022860 | |
| Drug | Bastadin 10 | 9.64e-05 | 4 | 92 | 2 | CID009589366 | |
| Drug | NSC7524 | 9.69e-05 | 182 | 92 | 6 | CID000005657 | |
| Drug | alpha-conotoxin SI | 1.07e-04 | 23 | 92 | 3 | CID000163979 | |
| Drug | lamotrigine | 1.09e-04 | 116 | 92 | 5 | CID000003878 | |
| Drug | Gossypol [303-45-7]; Up 200; 7.8uM; HL60; HT_HG-U133A | 1.09e-04 | 186 | 92 | 6 | 2202_UP | |
| Drug | AC1NBU2S | 1.13e-04 | 117 | 92 | 5 | CID004473765 | |
| Drug | propofol | 1.26e-04 | 191 | 92 | 6 | CID000004943 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | 1.26e-04 | 191 | 92 | 6 | 1240_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | 1.30e-04 | 192 | 92 | 6 | 2572_UP | |
| Drug | succinylcholine | 1.32e-04 | 64 | 92 | 4 | CID000005314 | |
| Drug | mibefradil | 1.32e-04 | 64 | 92 | 4 | CID000060662 | |
| Drug | Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.38e-04 | 194 | 92 | 6 | 6068_DN | |
| Drug | T0702 | 1.38e-04 | 25 | 92 | 3 | CID000005908 | |
| Drug | Sulfamerazine [127-79-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 3718_DN | |
| Drug | Clorocruoro Hem | 1.43e-04 | 123 | 92 | 5 | CID003518809 | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 5339_UP | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.74e-08 | 3 | 90 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.74e-08 | 3 | 90 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | trichothiodystrophy (is_implicated_in) | 2.75e-05 | 3 | 90 | 2 | DOID:0111866 (is_implicated_in) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.75e-05 | 3 | 90 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 5.50e-05 | 4 | 90 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 5.50e-05 | 4 | 90 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 5.50e-05 | 4 | 90 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 5.50e-05 | 4 | 90 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 5.50e-05 | 4 | 90 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 5.50e-05 | 4 | 90 | 2 | C0242013 | |
| Disease | Abnormality of the eye | 1.91e-04 | 7 | 90 | 2 | C4316870 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.91e-04 | 7 | 90 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 2.55e-04 | 8 | 90 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease | 2.89e-04 | 42 | 90 | 3 | cv:C0007959 | |
| Disease | esophageal squamous cell carcinoma | 7.02e-04 | 13 | 90 | 2 | EFO_0005922 | |
| Disease | Alzheimer disease, educational attainment | 9.73e-04 | 247 | 90 | 5 | EFO_0011015, MONDO_0004975 | |
| Disease | electrocardiography | 1.20e-03 | 530 | 90 | 7 | EFO_0004327 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 1.21e-03 | 17 | 90 | 2 | cv:C0270914 | |
| Disease | Mood Disorders | 1.77e-03 | 168 | 90 | 4 | C0525045 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.90e-03 | 80 | 90 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | otosclerosis | 1.97e-03 | 81 | 90 | 3 | EFO_0004213 | |
| Disease | sudden cardiac arrest | 2.11e-03 | 83 | 90 | 3 | EFO_0004278 | |
| Disease | liver fibrosis measurement | 2.34e-03 | 86 | 90 | 3 | EFO_0010576 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.43e-03 | 24 | 90 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Attention deficit hyperactivity disorder | 2.43e-03 | 24 | 90 | 2 | C1263846 | |
| Disease | malaria (is_implicated_in) | 2.43e-03 | 24 | 90 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | arachidonic acid measurement | 2.64e-03 | 25 | 90 | 2 | EFO_0006808 | |
| Disease | forced expiratory volume | 2.84e-03 | 789 | 90 | 8 | EFO_0004314 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.04e-03 | 195 | 90 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFALLGMQLFGGQFN | 626 | O00555 | |
| PAGAANFLAMVDNLQ | 71 | Q9Y5Z0 | |
| FGANQLNAPARLGIM | 246 | Q9NP70 | |
| MEKNPFVLGANLNGG | 751 | Q8IUX7 | |
| MFAIQPGLAEGGQFL | 1 | Q8TAB5 | |
| MGLQGSAQHFNIFPL | 56 | Q8IVJ8 | |
| QPFNRAMLFNVGFQE | 206 | O43286 | |
| LGMQLFGGQFNFQDE | 626 | Q00975 | |
| LFLFEQLPQGEGGHM | 756 | A7MBM2 | |
| NIALIQPGFSLMNFD | 11 | P55895 | |
| QMHNAGFGPLTDLVF | 296 | P10276 | |
| QMHNAGFGPLTDLVF | 296 | P10826 | |
| QLAAPFGFLGMQSLV | 451 | Q86XR2 | |
| NKLADAGLPDNMFNG | 201 | Q7Z5L7 | |
| MLDNNGLQALPAQFS | 256 | Q9Y4C4 | |
| LTNPLGFMGINGDLN | 566 | Q96EF0 | |
| NFNNVIPEGMNLSFL | 186 | Q9NPH3 | |
| FIIFGANLSNPLNML | 341 | Q9NUN5 | |
| LGNFVMFPANGNIDL | 211 | P14415 | |
| SPNLNFMGQLLEFEE | 446 | Q9Y6W6 | |
| GQRIQAQEGDFPMPF | 16 | P24071 | |
| AGPFQQRGLFDFMLE | 16 | P07585 | |
| DQLAEMLPGVLQQFG | 116 | Q92597 | |
| GAGQPFAERLLMQFN | 956 | P54098 | |
| DNPNTGIGAFRFMLE | 206 | Q8IVB5 | |
| LGTAFFQQQQLPAAM | 51 | P30613 | |
| EPNQNYAGMLGLLVQ | 191 | Q92616 | |
| GNGFMIFLIHFDPNL | 41 | Q8NG92 | |
| LLNPAQVFDLMNGGP | 356 | Q86XP1 | |
| NAVGQMATDFAPGFQ | 421 | O00410 | |
| LAFDFLSQQNDNMGP | 1106 | Q8IZL2 | |
| FMNAENLGIVFGPTL | 421 | P52757 | |
| FMENAFELPTGAGLQ | 831 | P04114 | |
| EFVLAMGNYLNDGQP | 1021 | A4D2P6 | |
| GGNFLHSFNIPMQLK | 296 | Q9Y2K7 | |
| PFSKGIFLGNNNQAM | 546 | Q8N1I0 | |
| AGCIFIEMFQGQPLF | 286 | Q96Q40 | |
| FMGQLLNGRVLFPVN | 361 | P17927 | |
| FMGQLLNGRVLFPVN | 811 | P17927 | |
| AFLGNFQDNLQMLTP | 731 | Q8IVF7 | |
| MNIQEQGFPLDLGAS | 1 | O15169 | |
| FGDTELTQMFLPFGN | 411 | Q8N6W0 | |
| LQMPSEQAAGLYAGQ | 716 | P27658 | |
| NQMGVFNFVDDGSLP | 81 | Q9Y586 | |
| FAMGALPDLNQDGFA | 551 | O75578 | |
| MAKFALNQNLPDLGG | 1 | Q6NY19 | |
| DINMIQGNYGFLPEL | 86 | Q9BV79 | |
| NLMNAENLGIVFGPT | 411 | P15882 | |
| SPNFNFMGQLLDFER | 331 | Q16828 | |
| ALFLQEFNAPDIFMG | 86 | Q96ER3 | |
| CGLQEGFEPFAINMQ | 1216 | P21817 | |
| QGMFENFNIDGLFFP | 776 | Q92736 | |
| SFMQRQFGALLQPGV | 161 | Q9UL51 | |
| QGQVDFAFFMPCGEL | 226 | P59044 | |
| NAQFLPGFLMGDLPA | 31 | Q8NFH5 | |
| RFLFDMLNGQDPDQG | 1191 | Q96KN7 | |
| ELFMLGLPFLAAQNA | 91 | P32745 | |
| PGNIFANVNGLMAIQ | 381 | Q8TF66 | |
| NQMGVFNFVDDGSLP | 81 | Q13394 | |
| LPLHLNAAMFEANGG | 1821 | Q9P212 | |
| PFNNGQLVMGSFVKN | 166 | Q96RN1 | |
| FPFQQGPVNMDDGRL | 976 | Q5QGS0 | |
| ILIPFNMAGQLGGQQ | 121 | P78424 | |
| QALVLLQDMAGFAPF | 281 | Q9H469 | |
| LPQQFQGDQLMAYGG | 1221 | P25391 | |
| LPEMFVNSNGYNLGV | 2441 | Q8NFP9 | |
| NRMHAINGFVFGNLP | 266 | Q9BQS7 | |
| INGFVFGNLPELNMC | 271 | Q9BQS7 | |
| FGPFQNLESLMNVPL | 106 | Q96QE5 | |
| LCKNGFGPQFNGLMQ | 151 | Q99697 | |
| LDLAFNPNNDGADGM | 1981 | Q9UHV7 | |
| NAFVLPNGQMFVFTG | 296 | Q96E52 | |
| VFGTIGMFLQPLFQN | 471 | P17787 | |
| ILPNFLANGGDGFQM | 496 | P21589 | |
| QGGYLNPMAAFAAAQ | 281 | Q9BZC1 | |
| PGFGQFMAGQLSQKE | 381 | P51788 | |
| MQDGNFLLSALQPEA | 1 | Q9Y446 | |
| LGAFQFQPENIIQMF | 311 | Q8TC36 | |
| DPTLLFANAGMNQFK | 36 | P49588 | |
| FLNNNLLQAMPSGVF | 511 | O94991 | |
| MNPALGNQTDVAGLF | 1 | Q9NS64 | |
| PVQGMFENFNTDGLF | 761 | Q15413 | |
| CGLQEGFEPFAVNMN | 1216 | Q15413 | |
| NQMLYGLQSPGNIFL | 441 | Q9Y458 | |
| EQLMGVFPAASGNFL | 596 | Q9H0D6 | |
| LPGGLFNMNQLLANE | 366 | Q9ULI2 | |
| LMNGPGSLFASENFL | 391 | Q8IWR0 | |
| GAQVLGNQIMPGFLN | 691 | Q8IWR0 | |
| FDDIGRNFLMNPQNG | 251 | Q8WVY7 | |
| ALAAEMNFFQLPVSG | 376 | O75541 | |
| GPQGSLNLQAMYLDE | 51 | Q9NS98 | |
| LGEMLTLPQNFGNIF | 61 | A5PLN9 | |
| QLFLFFAMGSDVQPG | 841 | Q9NVE5 | |
| NIPFQMLLRGANAVG | 636 | P11498 | |
| LLNNLGNFINRAGMF | 646 | P56192 | |
| NHLPGGELMIQLFFV | 171 | Q96IK0 |